. . . . "Fas receptor"@cs . . . "FasR"@cs . . . "Fas receptor (CD95, APO-1, TNFRSF6, Fas antigen) je transmembr\u00E1nov\u00FD protein typu I z rodiny TNF receptor\u016F (TNF - tumor nekrotizuj\u00EDc\u00ED faktor). Je exprimov\u00E1n na povrchu mnoha bun\u011B\u010Dn\u00FDch typ\u016F (zejm\u00E9na bun\u011Bk thymu, aktivovan\u00FDch T lymfocyt\u016F, hepatocyt\u016F a srdce). Lymfomy T a B bun\u011B\u010Dn\u00E9ho p\u016Fvodu exprimuj\u00ED Fas konstitutivn\u011B ve velk\u00E9m mno\u017Estv\u00ED.V imunitn\u00EDm syst\u00E9mu hraje Fas receptor v\u00FDznamnou roli. Nav\u00E1z\u00E1n\u00EDm ligandu (FasL, CD95L, CD178) spou\u0161t\u00ED bun\u011B\u010Dnou smrt zvanou apopt\u00F3za, proto se mu tak\u00E9 \u0159\u00EDk\u00E1 receptor smrti. Interakci Fas receptor-Fas ligand vyu\u017E\u00EDvaj\u00ED cytotoxick\u00E9 T lymfocyty a NK bu\u0148ky k zab\u00EDjen\u00ED ne\u017E\u00E1douc\u00EDch bun\u011Bk. Fas je velmi d\u016Fle\u017Eit\u00FD pro perifern\u00ED toleranci. Prost\u0159ednictv\u00EDm Fas protein\u016F imunitn\u00ED syst\u00E9m eliminuje ji\u017E nepot\u0159ebn\u00E9 aktivovan\u00E9 lymfocyty a autoreaktivn\u00ED lymfocyty."@cs . . . "FAS receptoru"@cs . . "Fas"@cs . . . . "Fas receptor (CD95, APO-1, TNFRSF6, Fas antigen) je transmembr\u00E1nov\u00FD protein typu I z rodiny TNF receptor\u016F (TNF - tumor nekrotizuj\u00EDc\u00ED faktor). Je exprimov\u00E1n na povrchu mnoha bun\u011B\u010Dn\u00FDch typ\u016F (zejm\u00E9na bun\u011Bk thymu, aktivovan\u00FDch T lymfocyt\u016F, hepatocyt\u016F a srdce). Lymfomy T a B bun\u011B\u010Dn\u00E9ho p\u016Fvodu exprimuj\u00ED Fas konstitutivn\u011B ve velk\u00E9m mno\u017Estv\u00ED.V imunitn\u00EDm syst\u00E9mu hraje Fas receptor v\u00FDznamnou roli."@cs . "Fas receptor"@cs . . . . . "624207"^^ . . . "10521151"^^ . . . . . "20143"^^ . "554002973"^^ . . . . . . . . . . . . . "Fas receptor"@cs . "35"^^ . . . . "en"@cs . .